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ABSTRACT
The micronutrient selenium is present in proteins
as selenocysteine (Sec). In eukaryotes and archaea,
Sec is formed in a tRNA-dependent conversion
of O-phosphoserine (Sep) by O-phosphoseryl-
tRNA:selenocysteinyl-tRNA synthase (SepSecS).
Here, we present the crystal structure of
Methanococcus maripaludis SepSecS complexed
with PLP at 2.5A ˚ resolution. SepSecS, a member
of the Fold Type I PLP enzyme family, forms an (a2)2
homotetramer through its N-terminal extension.
The active site lies on the dimer interface with
each monomer contributing essential residues. In
contrast to other Fold Type I PLP enzymes, Asn247
in SepSecS replaces the conserved Asp in binding
the pyridinium nitrogen of PLP. A structural com-
parison with Escherichia coli selenocysteine lyase
allowed construction of a model of Sep binding
to the SepSecS catalytic site. Mutations of three
conserved active site arginines (Arg72, Arg94,
Arg307), protruding from the neighboring subunit,
led to loss of in vivo and in vitro activity. The lack
of active site cysteines demonstrates that a
perselenide is not involved in SepSecS-catalyzed
Sec formation; instead, the conserved arginines
may facilitate the selenation reaction. Structural
phylogeny shows that SepSecS evolved early in
the history of PLP enzymes, and indicates that
tRNA-dependent Sec formation is a primordial
process.
INTRODUCTION
The indirect tRNA-dependent pathways of aminoacyl-
tRNA formation, in which a noncognate amino acid
bound to tRNA is converted to the cognate one, are
widely distributed in nature. In fact, the tRNA-dependent
pathways for Gln and Asn formation are evolutionarily
older than the corresponding direct aminoacylation
route catalyzed by the aminoacyl-tRNA synthetases (1).
Although selenocysteine occurs in organisms from all
three domains of life (2,3), Sec-tRNA is synthesized solely
by the indirect route; actually it is the only natural amino
acid found in proteins for which a cognate aminoacyl-
tRNA synthetase did not evolve. Seryl-tRNA synthetase
(SerRS) forms Ser-tRNA
Sec in bacteria (4), archaea (5,6)
and eukaryotes (7). Using the selenium donor selenopho-
sphate bacteria convert this misacylated aminoacyl-tRNA
species to Sec-tRNA
Sec by the action of the SelA protein, a
PLP-dependent selenocysteine synthase (3). Some metha-
nogenic archaea harbor a gene that was thought to encode
a SelA homolog (e.g. MJ0158), but its product is unable to
synthesize Sec-tRNA
Sec in vitro (6).
On the other hand, eukaryotes and archaea require an
additional phosphorylation step catalyzed by O-phospho-
seryl-tRNA
Sec kinase (PSTK) (8–10) and convert the
resulting Sep-tRNA
Sec to Sec-tRNA
Sec by Sep-tRNA:Sec-
tRNA synthase (SepSecS) (11,12). An unexpected and
important property of the human SepSecS protein is the
fact that it is the target antigen for soluble liver antigen/
liver–pancreas (SLA/LP) autoantibodies (13–15) that are
found in about a quarter of the patients with autoimmune
hepatitis (16). The reactions catalyzed by PSTK and
SepSecS are reminiscent of the indirect pathway of
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where Sep-tRNA
Cys is converted to Cys-tRNA
Cys by
Sep-tRNA:Cys-tRNA synthase (SepCysS), a PLP-depen-
dent enzyme carrying out a b-replacement on tRNA-
bound Sep. The crystal structure of Archaeoglobus
fuldgidus SepCysS has been reported (18).
The initial characterization of SepSecS revealed that
this protein is a PLP-dependent enzyme (11,12). In nature
such enzymes are abundant; in some microbial genomes
they represent as much as 1.5% of all genes (19). They
have many diverse functions and are often involved in
amino acid biosynthesis (20). The structures of three other
PLP-dependent enzymes that use substrates (selenocys-
teine, cysteine) chemically similar to those of SepSecS
have been solved. One is the A. fulgidus SepCysS
(AFSepCysS) (18), while another one is Escherichia coli
selenocysteine lyase (ECCsdB) (21), an enzyme that
converts selenocysteine to alanine and elemental selenium
(22). The last enzyme is the E. coli cysteine desulfurase
(ECIscS) that catalyzes the desulfuration of cysteine (23).
The reactions catalyzed by these enzymes are illustrated in
Scheme 1; SepSecS and SepCysS carry out b-replacements
on tRNA-bound Sep, while selenocysteine lyase removes
the b-substituent of Sec to form elemental selenium,
and cysteine desulfurase catalyzes the fragmentation of
cysteine to alanine and elemental sulfur. Biochemical data
on SepSecS and SepCysS currently do not exist.
Here, we report the crystal structure of Methanococcus
maripaludis SepSecS (MMPSepSecS) at 2.5A ˚ resolution
and perform a structural comparison with ECCsdB and
AFSepCysS. We propose active site residues important for
the enzymatic function of MMPSepSecS by employing a
combination of mutational in vivo and in vitro activity
analyses. Finally, we present a structural phylogeny of the
Fold Type I family of PLP-dependent enzymes that
documents the evolutionary history of SepSecS.
MATERIALS AND METHODS
General
Oligonucleotide synthesis and DNA sequencing was
performed by the Keck Foundation Biotechnology
Resource Laboratory at Yale University. [
14C]Serine
(163mCi/mmol) and [a-
32P]ATP (10mmol/mCi) were
obtained from Amersham Pharmacia Biosciences
(Piscataway, NJ, USA). The E. coli BL21-CodonPlus
(DE3)-RIL strain and the pUC18 vector were from
Stratagene (LaJolla, CA, USA). The pET15b and the
pACYC184 vectors were from Novagen (San Diego, CA,
USA). Nickel-nitriloacetic acid agarose was from Qiagen
(Valencia, CA, USA). Nickel-sepharose and Resource
PHE were from GE Healthcare Bio-Sciences KK (Tokyo,
Japan).
Bacterial strains andplasmids
Construction of the E. coli DselA deletion strain JS1
(DE3), cloning of the M. maripaludis SepSecS gene
(MMP0595) and the E. coli SelD gene into the pET15b
vector, of the M. maripaludis tRNA
Sec gene into the
pUC18 vector, and of the M. jannaschii PSTK gene into
the pACYC184 vector were described previously (11). The
M. maripaludis SepSecS mutants R72A, R72Q, R72K,
R94A, R94Q, H166A, H166F, H166Q, R307A, R307Q,
R307K, Q102A, K278A, N247A, D277A, and K278A
were generated using the QuikChange site-directed muta-
genesis kit (Stratagene) and cloned into the pET15b vector
with an N-terminal His-tag. An N-terminal 1–34SepSecS
deletion mutant was constructed by PCR using the
primers 50-CCGCTCGAGCATCGGAAAATTCCTGA
AAACGGAATTGATGACG-30 and 50-GCTAGTTAT
TGCTCAGCGGTGGCAGC-30 and the pET15b-
sepsecS plasmid DNA as the template. The resulting
DNA fragment was digested with BamHI and XhoI and
re-inserted into the pET15b vector.
Protein expression and purification
Expression and puriﬁcation of the M. maripaludis wild-
type and mutant SepSecS proteins and the E. coli SelD
(used for biochemical experiments) was done as described
previously using Ni-NTA column chromatography (11).
Puriﬁcation of the wild-type SepSecS used for crystal-
lization involved two chromatographic steps. Brieﬂy,
pET15b-sepsecS was transformed into the E. coli BL21-
CodonPlus (DE3)-RIL strain, cells were grown to
A600=0.6 and gene expression was induced with
0.4mM IPTG. After growth for 17h at 208C, cells were
harvested, resuspended in 50mM Tris–HCl (pH 7.0),
300mM NaCl, 10mM PLP, 5mM 2-mercaptoethanol,
10% glycerol, 1mM PMSF and gently sonicated. After
centrifugation at 14000g for 30min, the supernatant was
collected and puriﬁed by sequential passage through a
Ni-Sepharose and a Resource PHE chromatography
column.
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Scheme 1. Graphic representation of the reaction schemes. (A)
MMPSepSecS catalyzes the conversion of tRNA
Sec-bound Sep to Sec.
(B) AFSepCysS mediates the tRNA
Cys-dependent transformation of
Sep to Cys. (C) ECCsdB converts selenocysteine to alanine and
elemental selenium. (D) ECIscS converts cysteine to alanine and
elemental sulfur.
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A 0.5ml sample of a 1.5mg/ml puriﬁed solution of
selenomethionine-labeled MMPSepSecS was loaded onto
a HiPrep 16/60 Sephacryl S-300 HR column (GE
Healthcare). The column was run at 0.5ml/min in the
same buﬀer as crystallization, containing 20mM HEPES
(pH 7.0), 300mM NaCl, 10mM PLP and 5mM DTT. The
elution volume of MMPSepSecS was compared to the
elution volumes of other oligomeric proteins according to
the GE healthcare web site (http://www.gelifesciences.
co.jp/catalog/pdf_attach/18106088AC.pdf).
Crystallization, structure determination and refinement
The puriﬁed SepSecS was dialyzed against crystallization
buﬀer, containing 20mM HEPES–NaOH (pH 7.0), 10mM
PLP and 5mM DTT, 300mM NaCl andwas concentrated.
Crystals of M. maripaludis SepSecS were grown within a
day at 208C by the sitting-drop vapor diﬀusion method.
Drops were prepared by mixing equal volumes of the 6mg/
ml SepSecS solution and the reservoir solution, containing
45mM HEPES–NaOH (pH 7.0), 10mM MES–HCl (pH
6.5), 90mM KCl, 9mM CaCl2, 160mM MgSO4 and 10%
PEG550MME. Selenomethionine-labeled SepSecS was
prepared by the conventional method and was puriﬁed in
the same manner as the wild-type.
The SepSecS crystals were ﬂash-cooled in a nitrogen
stream at 100K. All diﬀraction data sets were collected
at the BL41XU at SPring-8 (Harima, Japan), and were
processed with the HKL2000 suite. The crystals belong to
the primitive monoclinic space group P21, with unit-cell
parameters a=75.7, b=108.1, c=110.4A ˚ , b=978.
There are four SepSecS molecules in the asymmetric
unit. A multiwavelength anomalous dispersion (MAD)
data set of the selenomethionine-substituted crystals was
collected, and was used to search for the locations of
the selenium atoms by using the program SnB (24).
Subsequent phase reﬁnements were performed with the
program SHARP (25), and the model was manually built
into the electron density maps by using the program O
(26). The model was reﬁned against reﬂections up to 2.5A ˚
resolution by using the program CNS (27). The backbones
of all residues were clearly deﬁned in the ﬁnal 2Fo Fc
electron density maps. Graphic representations were
prepared with CueMol (http://www.cuemol.org).
Statistics on data collection, phasing and reﬁnement are
shown in Tables 1 and 2.
Invivo SepSecS assay
The M. maripaludis wild-type and mutant SepSecS genes
were transformed into the DselA E. coli JS1 strain with
or without the M. jannaschii PSTK gene. Aerobic over-
night cultures were streaked in aerobic conditions on
LB-agar plates supplemented with 0.01mM IPTG, 1mM
Na2MoO4,1 mMN a 2SeO3 and 50mM sodium formate.
The plates were placed in an anaerobic incubation jar that
was ﬂushed with an N2:C O 2:H 2 (90:5:5) gas mix three
times to give an anaerobic atmosphere and then grown for
16hat378Cand36hat308C. Theplateswerethenoverlaid
with agar containing 1mg/ml benzyl viologen (BV), 0.25M
sodium formate and 25mM KH2PO4 adjusted to pH 7.0.
The appearance of a blue/purple color is the indication of
active formate dehydrogenase H (FDHH).
Preparation and purification oftRNA gene transcripts
The M. maripaludis tRNA
Sec used as substrate in the
in vitro assays was synthesized by in vitro T7 RNA
polymerase run-oﬀ transcription as described (28).
The tRNA
Sec gene together with the T7 promoter was
constructed from overlapping chemically synthesized
oligonucleotides, cloned into the pUC18 plasmid and
puriﬁed from E.coli DH5a transformants using a
MaxiPrep plasmid puriﬁcation kit (Qiagen). The puriﬁed
Table 1. Data collection and phasing statistics
X-ray source SPring-8 BL41XU
Peak Edge Reml Remh
Data collection statistics SeMet
Wavelength (A ˚ ) 0.9791 0.9793 0.9820 0.9770
Resolution (A ˚ ) 50–2.5 (2.54–2.5) 50–2.5 (2.54–2.5) 50–2.5 (2.54–2.5) 50–2.5 (2.54–2.5)
Unique reﬂections 59938 59274 59463 59123
Redundancy 5.0 (2.4) 4.9 (2.3) 4.8 (2.2) 4.8 (2.0)
Completeness (%) 97.9 (86.1) 97.6 (86.1) 97.0 (81.2) 96.6 (79.3)
I/s(I) 17.0 (2.9) 16.4 (2.7) 16.3 (2.6) 15.3 (2.4)
Rsym 0.135 (0.258) 0.127 (0.272) 0.125 (0.261) 0.127 (0.272)
Phasing statistics
No. of Se sites 31 31 31 31
Phasing power
Iso (cen./acen.) 0.633/0.587 – 1.006/0.879 0.706/0.653
Ano 1.399 0.79 0.107 0.811
Rcullis
Iso (cen./acen.) 0.896/0.833 – 0.713/0.767 0.749/0.794
Ano 0.754 0.89 0.987 0.89
Mean FOM
Cen./Acen. 0.406/0.461
The numbers in parentheses are for the last shell.
Rsym ¼
P
i
 I   Ii
       =
P
i
Ii: Rcullis ¼
P
jFPH þ FPj Fcalc
H
       =
P
FPH jj .
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The in vitro transcription reaction was performed at
378C for 5h in buﬀer containing 40mM Tris–HCl (pH 8),
22mM MgCl2, 25mM DTT, 2mM spermidine, 50mg/ml
BSA, 0.1mg/ml pyrophosphatase, 4mM of each
nucleoside triphosphate, BstNI-digested vector containing
the tRNA
Sec gene (60mg/ml) and 1mM T7 RNA
polymerase. The tRNA
Sec transcript was puriﬁed by
electrophoresis on a 12% denaturing polyacrylamide gel.
Full-length tRNA was eluted and desalted on Sephadex
G25 Microspin columns (Amersham). The tRNA
transcripts were refolded by heating for 5min at 708C
in buﬀer containing 10mM Tris–HCl (pH 7.0), followed
by addition of 5mM MgCl2 and immediate cooling
on ice (5).
Preparation of
32P-labeled Sep-tRNA
Sec
Refolded tRNA
Sec transcript was
32P-labeled on the
30 terminus by using the E. coli CCA-adding enzyme and
[a-
32P]AMP (Amersham) as previously described with
some modiﬁcations (29). Brieﬂy, 6mg of tRNA
Sec trans-
cript was incubated with the CCA-adding enzyme and
[a-
32P]ATP (50mCi) for 1h at room temperature in buﬀer
containing 50mM Tris–HCl (pH 8.0), 20mM MgCl2,
5mM DTT and 50mM sodium pyrophosphate. After
phenol/chloroform extraction the sample was passed over
a Sephadex G25 Microspin column (Amersham) to
remove excess ATP (30).
The recovered [
32P]-labeled tRNA
Sec was serylated and
phosphorylated by M. maripaludis SerRS (5mM) and
M. jannaschii PSTK (1mM) for 75min at 378C in buﬀer
containing 50mM HEPES (pH 7.5), 10mM MgCl2,
20mM KCl, 1mM DTT, 1mM serine and 10mM ATP.
After phenol/chloroform extraction aminoacylated
Sep-tRNA
Sec was ethanol precipitated at  208C for
45min and collected as a pellet by centrifugation at
10000g at 48C for 30min. After washing the pellet with
70% ethanol, it was allowed to dry on ice in order to avoid
deacylation.
To check levels of serylation and Ser!Sep conversion
1ml aliquots at the start and end of the reaction were
quenched on ice with 3ml of 100mM sodium citrate
(pH 4.75) and 0.66mg/ml of nuclease P1 (Sigma).
Following nuclease P1 digestion at room temperature
for 1h, 1.5ml of the sample was spotted onto polyethyl-
eneimine (PEI) cellulose 20cm 20cm thin layer chroma-
tography (TLC) plates (Merck). To separate the
Sep-[
32P]AMP spot from [
32P]AMP and any remaining
Ser-[
32P]AMP the plates were developed for 75min in
buﬀer containing 100mM ammonium acetate, 5% acetic
acid. The plates were exposed on an imaging plate
(FujiFilms) for 14h, scanned using a Molecular
Dynamics Storm 860 scanner and quantiﬁed using the
ImageQuant densitometry software. The amount of
Sep-tRNA
Sec formed can be calculated by dividing the
intensity of the Sep-[
32P]AMP spot by the sum of the
intensities of all spots (Sep-[
32P]AMP, [
32P]AMP and
Ser-[
32P]AMP).
In vitro conversion of Sep-tRNA
Sec toCys-tRNA
Sec
Puriﬁed wild-type or mutant MMPSepSecS (1mM) was
incubated with 1mM
32P-labeled Sep-tRNA
Sec in buﬀer
containing 50mM HEPES (pH 7.0), 20mM KCl, 10mM
MgCl2, 5mM DTT, 2mM PLP and 500mM sodium
thiophosphate. Reactions were carried out anaerobically
at 378C over 40min. At each time point taken, 1ml
reaction aliquots were quenched on ice with 3mlo f
100mM sodium citrate (pH 4.75) and 0.66mg/ml of
nuclease P1 (Sigma). Following nuclease P1 digestion,
1.5ml of the sample was spotted onto PEI cellulose TLC
plates that were developed, scanned and quantiﬁed as
described above. To separate the Cys-[
32P]AMP spot from
the Sep-[
32P]AMP, the [
32P]AMP and any remaining
Ser-[
32P]AMP spots the plates were developed for 75min
in buﬀer 100mM ammonium acetate, 5% acetic acid. The
plates were exposed on an imaging plate (FujiFilms) for
14h, scanned using a Molecular Dynamics Storm 860
scanner and quantiﬁed using the ImageQuant densitome-
try software. The amount of Cys-[
32P]AMP formed was
calculated by dividing the intensity of the Cys-[
32P]AMP
spot by the sum of the intensities of all spots
(Cys-[
32P]AMP, Sep-[
32P]AMP, [
32P]AMP and Ser-
[
32P]AMP). The added elevated concentration of PLP
was used to assure that the mutant enzymes were
saturated with the cofactor.
In vitro conversion of Sep-tRNA
Sec toSec-tRNA
Sec
The Sep-to-Sec conversion reaction was carried out as
described before (11). Brieﬂy, puriﬁed tRNA
Sec (10mM)
was incubated with M. maripaludis SerRS (6mM) and
M. jannaschii PSTK (3mM) in reaction buﬀer containing
100mM[
14C]Ser, 100mM HEPES (pH 7.0), 10mM KCl,
10mM magnesium acetate, 1mM DTT and 0.1mg/ml
BSA at 378C for 1h. The aminoacylated Sep-tRNA
Sec
Table 2. Structure reﬁnement statistics
Reﬁnement statistics Se-Met
Resolution (A ˚ ) 50–2.5
No. of atoms
Protein 13552
Water 146
PLP 160
SO4 10
Luzzati coordinate error (A ˚ ) 0.3
Cross-validated Luzzati coordinate error (A ˚ ) 0.39
RMSD of
Bond length (A ˚ ) 0.007
Bond angle (8) 1.39
Dihedral angle (8) 22.2
Improper angle (8) 0.89
Average B factor (A ˚ 2) 38.5
Ramachandran plot
Core region (%) 88.2
Additionally allowed region (%) 11.3
Generously allowed region (%) 0.3
Disallowed region (%) 0.2
Rwork/Rfree 0.208/0.269
Rwork=|Fo Fc|/Fo for reﬂections of work set.
Rfree=|Fo Fc|/Fo for reﬂections of test set (10% of total
reﬂections).
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by passage over a Sephadex G25 Microspin column
(Amersham) and ethanol precipitation. Puriﬁed wild-type
SepSecS or the R72Q mutant was incubated with 10mM
Sep-tRNA
Sec and 100mM puriﬁed E. coli SelD in reaction
buﬀer containing 100mM HEPES pH 7.0, 300mM KCl,
10mM MgCl2, 1mM DTT and 250mMN a 2SeO3. All
buﬀers were prepared anaerobically and the reaction was
carried out in an anaerobic chamber at 378C. After 30min
incubation the reaction was stopped by phenol extraction
and the tRNAs were puriﬁed by application on a
Sephadex G25 Microspin column (Amersham) and
ethanol precipitation. Puriﬁed tRNA products were
deacylated in 20mM NaOH at room temperature for
10min. The released amino acids were oxidized with
performic acid and spotted onto silica gel 60 TLC
aluminium sheets (Merck) that were subsequently devel-
oped in 85% ethanol.
Alignment and phylogeny
The STAMP (31) structural superposition algorithm in
the Multiseq 2.0 module of VMD 1.8.6 (32) was used to
establish a structure-based alignment between SepSecS
and the other members of the fold type I PLP-dependent
family. The structural similarity measure QH (33) was
used to determine evolutionary distances between
members of the fold type I group for the structural
phylogeny shown in Figure 8. The tree was drawn using
the programs NEIGHBOR and DRAWTREE in the
Phylip 3.66 package (34). A similar structure-based
alignment was used for the structure-based sequence
alignment shown in Figure 2. First, SepSecS was
structurally aligned to SepCysS, IscS and CsdB. This
structure-based alignment was then supplemented with
three additional SepSecS sequences, which had been
previously aligned to MMPSepSecS with CLUSTAL
(35). Some alignment ambiguities were corrected by
manual adjustment to the structure-based sequence
alignment.
Accession numbers
The Protein Data Bank (http://www.rscb.org/pdb) acces-
sion number for the coordinates of MMPSepSecS
conjugated with PLP is 2Z67.
RESULTS
Experimental outline
The MMPSepSecS protein was overproduced in E. coli,
then puriﬁed by two column chromatographic steps, and
crystallized. Using selenomethionine-labeled protein the
structure was solved by the MAD method. The complex of
SepSecS with covalently-bound PLP was reﬁned to an
Rfree of 26.9% at 2.5A ˚ resolution.
In this ﬁrst characterization of M. maripaludis SepSecS
(MMPSepSecS) activity, we used the genetic complemen-
tation of an E. coli DselA deletion strain as an in vivo test.
When grown anaerobically, E. coli produces the selenium-
dependent formate dehydrogenase FDHH. Its activity
enables the cells to reduce benzyl viologen (BV) in the
presence of formate; this is usually observed by a blue/
purple color in agar overlay plates under anaerobic
conditions (36). Furthermore, we employed two in vitro
tests. The ﬁrst detects the enzyme’s ﬁnal reaction product,
Sec-tRNA
Sec, as determined by TLC of Sec released
from tRNA
Sec (11). Given the diﬃculty in working with
selenophosphate (availability and oxygen sensitivity) we
used thiophosphate as a surrogate substrate to measure
the time course of Cys-tRNA
Sec formation by SepSecS.
In this assay,
32P-labeled Sep-tRNA
Sec was incubated
anaerobically with wild-type or mutant SepSecS proteins
and thiophosphate. After nuclease P1 digestion of the
tRNA in the reaction mixture, the product Cys-[
32P]AMP
was separated from Sep-[
32P]AMP by TLC and
quantitated.
Overall structure of M.maripaludis SepSecS
The MMPSepSecS protein adopts an L-shaped structure
consisting of the N-terminal extension domain (1–130),
a catalytic domain (131–309) and a C-terminal domain
(353–436) (Figure 1A). Long, kinked helices (310–352)
connect the catalytic and C-terminal domains. The PLP
molecule is covalently bound to the conserved Lys residue
K278 (Figure 2) at the active site. As can be seen in
Figure 1, the overall architecture of MMPSepSecS is
similar to the Fold Type I (20) PLP enzymes AFSepCysS
(18) and ECCsdB (21) (Figure 1). These enzymes consist
of a catalytic domain similar to that of MMPSepSecS, and
a ‘small domain’, formed by the N-terminal polypeptide
and C-terminal polypeptide, which also resembles the
MMPSepSecS C-terminal domain (Figure 1B and C)
(18,21). We constructed a structure-based sequence
alignment (Figure 2) in order to accurately compare
MMPSepSecS to three PLP enzymes, AFSepCysS,
ECCsdB and ECIscS, that act upon chemically similar
substrates. According to structural similarity measures
SepCysS, CsdB and IscS are signiﬁcantly more closely
related to each other than they are to SepSecS (Figure 3).
Sequence relationships show a similar trend with SepCysS,
CsdB and IscS sharing 24 identical residues while these
proteins have only 8 residues in common with SepSecS
(Figure 2). The alignment also shows that the archaeal
SepSecS proteins lack the C-terminal extension that
has been identiﬁed as the major antigenic region for the
SLA/LP autoantibodies (37).
In solution, SepSecS is a tetramer as revealed by gel
ﬁltration (Figure 4E). The asymmetric unit of the crystal
contains four SepSecS molecules (chains A, B, C and D)
related by non-crystallographic symmetry, suggesting that
SepSecS forms a homotetramer (dimer of homodimers)
(Figure 4A). The four molecules are mostly identical, with
root mean square (RMS) deviations of about 0.5A ˚
between the subunits. The N-terminal extension domain
of each subunit plays a pivotal role in the tetrameric
organization of SepSecS. These domains interact with
each other to form a hydrophobic core (chain A with
chain D, and chain B with chain C), which involves
inward-facing hydrophobic residues protruding from the
helices, a1, a2 and a4 (Figure 4B). Thus, the N-terminal
Nucleic Acids Research, 2008, Vol. 36, No. 4 1191extension facilitates tetramer formation and its deletion is
predicted to produce a dimeric SepSecS. Interestingly,
AFSepCysS (18) and ECCsdB (21) lack the N-terminal
extension domain and form dimers (Figure 4C and D).
We investigated whether SepSecS would be active in a
homodimeric form by assaying the enzymatic activity of
an MMPSepSecS protein that lacks the N-terminal
extension residues 1–34. The 1–34SepSecS enzyme did
not form Sec-tRNA
Sec in vivo (Figure 5). It was not able to
rescue selenoprotein biosynthesis in our in vivo comple-
mentation test of the E.coli DselA deletion strain. Since the
active site of SepSecS, like other PLP enzymes, is formed
at the dimer interface it is clear that SepSecS would not
function as a monomer. Why the tetrameric organization
of SepSecS is critical for function remains unclear, but it is
possible that the quaternary structure of SepSecS is
important for tRNA recognition. In such a scenario,
when a tRNA acceptor stem is bound to the active site of
one dimer, the other dimer in the tetramer could be
interacting with other regions of the tRNA.
Recognition of PLP
As in other Fold Type I PLP enzymes the active sites of
MMPSepSecS lie on the dimer interface with each
monomer contributing essential residues (20). The active
site of chain A is formed by chains A and B that both
recognize the PLP molecule (Figure 6). The catalytic
domain harbors a seven-stranded b–sheet, with only the
sixth b–strand being antiparallel; this is a common feature
of Fold Type I PLP enzymes (20,38) including
AFSepCysS (18) and ECCsdB (21). In the MMPSepSecS
structure, PLP is covalently bound via a Schiﬀ base to the
strictly conserved Lys278 (chain A) (Figure 2), which is
located between the sixth and seventh b strand in the
active site (Figure 6A). Indeed, a Lys278Ala mutation
abolishes MMPSepSecS catalytic activity as shown both
in vivo by the lack of BV reduction by FDHH (Figure 5),
and in vitro by the inability of the Lys278Ala mutant to
form Cys-tRNA
Sec (Figure 7).
All known Fold Type I PLP enzymes possess a critical
aspartate that contacts the N1 atom of the pyridine ring
(39), which is thought to further increase the electron sink
character of the PLP cofactor. SepSecS is an exception
to this paradigm, Asn247 is found in the correspond-
ing position, and it forms a hydrogen bond with the
pyridinium nitrogen (Figure 6). The other ‘noncon-
forming’ enzyme is SepCysS where the structure also
reveals a similar Asn contact with PLP (18). The
replacement of Asn247 with the uncharged Ala247 yields
a partially active enzyme (Figures 5 and 7). The phosphate
moiety of Sep appears to be such a good leaving group
that the presence of an Asp or Asn residue is not required
for the catalytic activity of SepSecS.
The aromatic pyridine ring of PLP is sandwiched
between His166 (chain A) and Ala249 (chain A) through
hydrophobic interactions at the bottom of the catalytic
site (Figure 6). This recognition mode is commonly
observed in the structures of Fold Type I PLP enzymes
where the His residue increases the electron sink character
of PLP’s pyridine ring through the stacking interactions
with it and may also play a role in substrate activation and
acid base catalysis. In the latter case, the His residue
makes a direct hydrogen bond with the critical aspartate
that contacts the N1 atom of the coenzyme pyridine ring
in all Fold Type I PLP enzymes (see above discussion) and
is thus thought to assist in the dissipation of the negative
charge generated around PLP’s ring during catalysis (40).
Furthermore, the phosphate moiety hydrogen bonds with
the main-chain amide and carbonyl groups of Gly140 and
Ser168, respectively (Figure 6B). The MMPSepSecS
mutant His166Ala was partially active in forming Sec-
tRNA
Sec in vivo (Figure 5). In vitro, the His166Ala
MMPSepSecS mutant was partially active in forming
Cys-tRNA
Sec as can be seen by the increase in intensity of
the Cys-[
32P]AMP spot and the concomitant decrease of
the Sep-[
32P]AMP spot during the course of the reaction
(Figure 7B). Obviously, the mutant enzyme with Ala166
has PLP still in a partially functional position. A mutation
Figure 1. The overall architectures of SepSecS and related enzymes.
(A) Stereo view of the MMPSepSecS structure. The N-terminal domain
(residues 1–130), the catalytic domain (residues 131–309), the linker
helix (310–352) and the C-terminal domain (residues 353–434) are
colored yellow, green, blue and pink, respectively. The carboxy-
terminal two residues are disordered. The PLP molecule bound to the
active site is shown as a ball and stick model. (B) Stereo view of the
AFSepCysS structure in the same orientation as (A) (18). The small
domain, the linker helices and the catalytic domain are colored pink,
blue and green, respectively. (C) Stereo view of the ECCsdB structure
in the same orientation as (A) (21). The coloring scheme is the same
as in (B).
1192 Nucleic Acids Research, 2008, Vol. 36, No. 4Figure 2. Structure-based amino acid sequence alignment. The alignment includes representative SepSecS sequences from two archaea
(M. maripaludis and M. kandleri) and two eukaryotes (H. sapiens and T. thermophila) as well as A. fulgidus SepCysS, E. coli IscS and E. coli
CsdB. Amino acids are colored according to residue types, and strictly conserved residues are marked ( ). The secondary structure of MMPSepSecS
is illustrated above the alignment, and the active site arginines are highlighted in blue. The autoimmune antigenic region of human SepSecS (37) and
a eukaryotic speciﬁc insertion are shown in gray boxes.
Nucleic Acids Research, 2008, Vol. 36, No. 4 1193of the corresponding His residue (position 143) in E. coli
aspartate aminotransferase also led to a functional enzyme
(40). In contrast, both the His166Gln and His166Phe
mutants were inactive in vivo (Figure 5). The lack of
enzymatic activity of the His166Phe mutant implicates
His166 in the catalytic mechanism and not only in
structural ring stacking interactions with the pyridine
ring of PLP. It is interesting to note that with the
exception of Plasmodium all known eukaryotic SepSecS
proteins contain Gln at a homologous position to 166 in
their sequences (Figure 2 and data not shown).
Since the catalytic pocket is formed in the dimerization
interface, chain B also contributes residues that participate
in PLP recognition. In particular, the guanidinium group
of Arg72 and the main-chain amide group of Arg307
(from chain B) hydrogen bond to the phosphate moiety of
PLP (Figure 6B). Mutations of Arg72 and Arg307 to Ala,
Gln or Lys resulted in MMPSepSecS mutants that were
signiﬁcantly less active in Sec-tRNA
Sec formation in vivo
(Figure 5) and Cys-tRNA
Sec formation in vitro
(Figure 7C). We also show that the Arg72Gln mutant
enzyme is unable to form Sec-tRNA
Sec in vitro
(Figure 7A).
Such PLP recognition diﬀers from that of AFSepCysS
(18) and ECCsdB (21) (Figure 8). Unlike in the
MMPSepSecS structure, the adjacent subunit of
ECCsdB does not come close to the active site. In
ECCsdB, an additional bab structural motif covers the
active site, presumably to stabilize the PLP and Sec
substrates inside the pocket. This motif also precludes
interaction between residues from the neighboring subunit
and the active site (Figure 8D). Although the active site of
AFSepCysS is formed by residues from chains A and B,
the chain B amino acids are located too distant for PLP
recognition (Figure 8E). The active sites of MMPSepSecS
and AFSepCysS are spacious enough to accommodate the
O-phosphoseryl-CCA end of the tRNA
Sec or tRNA
Cys
species, respectively.
Figure 3. Structural phylogeny of the Fold Type I PLP-dependent enzyme family. The phylogenetic tree depicts the evolutionary history of the Fold
Type I family. Branch lengths in the tree are proportional to structural diﬀerences between the members of the family according to the structural
similarity measure QH (see ‘Materials and methods’ section). The subfamily clusters are denoted by arced lines and under each subfamily name
(e.g. AT I) a representative enzyme name (e.g. aspartate aminotransferase) is given in parentheses. Isofunctional subfamilies are labeled only by their
corresponding enzyme names. Protein structures used to build the tree are noted according to PDB (46) or SCOP (47) codes.
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Our crystallization solution contained 10mM magnesium
sulfate. In the present structure, a strong electron density
(4.5s), presumably corresponding to a sulfate ion, was
observed adjacent to the PLP molecule of chains A and B
(Figure 8A). The sulfate ion is recognized by Arg94,
Ser95, Gln102 and Arg307 of chain B (Figure 8A). The
structure of ECCsdB with Sec bound to the active site
(Figure 8D) was reported (21). Using the CE program (41)
we superposed the active site structure of MMPSepSecS
onto that of ECCsdB. This allowed modeling of Sec from
CsdB into the MMPSepSecS active site (Figure 8B). The
distance between the selenium atom of the modeled Sec
and the sulfur atom of the bound sulfate is 3.74A ˚ .W e
overlaid a Sep molecule on the position of the modeled Sec
in the active site. The phosphate moiety of this modeled
Sep overlapped with the bound sulfate, suggesting that
this sulfate mimics the phosphate moiety of Sep attached
to tRNA
Sec. This allowed us to construct the Sep-binding
model of MMPSepSecS (Figure 8C). Mutations of Arg94,
Gln102 and Arg307 residues that according to our
Sep-binding model recognize the phosphate moiety of
Sep signiﬁcantly decreased the catalytic activity of
MMPSepSecS both in vivo (Figure 5) and in vitro
(Figure 7). While the distance of the Schiﬀ base linkage
between the C4a atom of PLP and the N  atom of Lys278
is 1.74A ˚ , the PLP C4a atom is 2.19A ˚ away from the
amino group of the modeled Sep; thus, the amino group of
Sep forms a Schiﬀ base with PLP as a reaction
intermediate.
The active site
We should ﬁrst note that the active site of MMPSepSecS
lacks a Cys residue. In contrast, the crystal structures of
ECCsdB (21) and of AFSepCysS (18) each possess a
cysteine-active site residue; Cys364 in ECCsdB and
Cys247 in AFSepCysS (Figure 8). As revealed by a
structural study (21), Cys364 of ECCsdB recognizes Sec
and withdraws its selenium to form perselenide as an
intermediate. Cys364 of ECCsdB resides in the bab
structural motif which does not exist in MMPSepSecS.
On the other hand, Cys247 (from the neighboring subunit)
of AFSepCysS is the candidate residue that forms a
Figure 4. The oligomeric states of SepSecS and related enzymes.
(A) The overall architecture of the MMPSepSecS tetramer. Chains A
and B, and chains C and D form dimers, respectively. The PLP
molecules bound to each subunit are shown as ball and stick models.
Chain A, chain B, chain C and chain D are colored pink, blue, green
and yellow, respectively. (B) The N-terminal extension domains of
chains B and C form a hydrophobic core that stabilizes the tetrameric
state of MMPSepSecS. Three a-helices (a1,a2,a4) are labeled. Chains B
and C are colored blue and green, respectively. (C) Stereo view of the
AFSepCysS dimer in the same orientation as (A) (18). Chains A and B
are colored pink and blue, respectively. The PLP molecules are shown
as ball and stick models. (D) Stereo view of the ECCsdB dimer in the
same orientation as (A) (21). The coloring scheme and the PLP repre-
sentation are the same as in (C). (E) Gel ﬁltration of selenomethionine-
labeled SepSecS on Sephacryl S-300. Absorbance at 280nm is shown as
a blue line. The elution volumes of other oligomeric proteins are
indicated in the chromatogram. The molecular weight of the
MMPSepSecS monomer is 50kDa. MMPSepSecS eluted at the size
expected for a tetrameric species.
Figure 5. In vivo assays of SepSecS mutants. Formation of Sec-tRNA
Sec in vivo is assayed by the ability of the wild-type MMPSepSecS and its
mutant variants (N-terminal deletion 1-34, R72A, R72Q, R72K, R94A, R94Q, H166A, H166F, H166Q, R307A, R307Q, R307K, Q102A, K278A,
N247A, D277A, K278A) to restore the BV reducing activity of the selenoprotein FDHH in the E.coli selA deletion strain JS1. Cotransformation of
the PSTK gene (indicated with +) from M. jannaschii is required for the formation of the Sep-tRNA
Sec intermediate.
Nucleic Acids Research, 2008, Vol. 36, No. 4 1195persulﬁde that is the sulfur source for enzyme-catalyzed
Cys-tRNA
Cys formation (18). The absence of such a Cys
active site residue indicates that the reaction mechanisms
and chemistries of SepSecS are fundamentally diﬀerent
from those of CsdB and SepCysS. Interestingly, SepSecS
has an active site arginine (Arg307) in a homologous
position to Cys247 in SepCysS (Figure 2).
The MMPSepSecS structure reveals three conserved
arginines (Arg72, Arg94 and Arg307) that are located in
proximity of each other and close to the active site; they
recognize the phosphate groups of PLP and presumably of
Sep acylated to tRNA
Sec (Figures 2 and 8A–C). Mutations
of Arg72, Arg94 and Arg307 to Ala, Gln or Lys yielded
MMPSepSecS enzymes that were unable to form Sec-
tRNA
Sec in vivo (Figure 5). Asp277 interacts electrostati-
cally with Arg72, and the Asp277Ala enzyme was also
inactive in vivo (Figure 5). The Arg72Gln, Arg94Gln and
Arg307Gln MMPSepSecS mutants were inactive in
forming Cys-tRNA
Sec in vitro (Figure 7). In addition to
the PLP-conjugated Lys278, Sep-binding arginines may
also facilitate general acid/base catalysis as was shown for
the tRNA modiﬁcation enzyme TrmH where an arginine
activated by a phosphate group acts as a general base (42).
DISCUSSION
The mechanism
SepSecS is a PLP enzyme catalyzing a b-replacement
(Scheme 1), leading to the exchange of a phosphate group
for a selenol moiety. We were interested to see if SepSecS
might employ a perselenide intermediate during catalysis,
which would require the presence of an active site cysteine.
There are four moderately-to-highly conserved cysteine
residues in the SepSecS sequences, which are found in
35–97% of the SepSecSs. Three of these cysteines (Cys146,
Cys214 and Cys237 in MMPSepSecS) are distant from the
active site and have no chance to contribute to catalysis.
Figure 7. In vitro conversion of Sep-tRNA
Sec to Sec-tRNA
Sec or Cys-tRNA
Sec.( A) Phosphorimages of TLC separation of [
14C]Sep and [
14C]Sec
recovered from the aa-tRNAs of the SepSecS activity assay (see ‘Materials and methods’ section). Sec was analyzed in its oxidized form as
selenocysteic acid (Secya). Lane 1, Ser marker; lane 2, Sep marker; lane 3, Sep-tRNA
Sec with wild-type MMPSepSecS; lane 4, Sep-tRNA
Sec with the
R72Q MMPSepSecS mutant. (B) Representative phosphorimage for the H166A SepSecS mutant of the separation of Ser-[
32P]AMP, Cys-[
32P]AMP,
[
32P]AMP and Sep-[
32P]AMP. At the indicated time points aliquots of the SepSecS reaction were quenched, digested with nuclease P1 and spotted
onto PEI-cellulose TLC plates as described in the ‘Materials and methods’ section. (C) Plot of Cys-tRNA
Sec formed versus time with 1mM of wild-
type and mutant SepSecS enzymes using Sep-tRNA
Sec (1mM) and thiophosphate (500mM) as substrates. Following quantiﬁcation of the intensities of
Ser-[
32P]AMP, Cys-[
32P]AMP, [
32P]AMP and Sep-[
32P]AMP using ImageQuant, the concentration of Cys-tRNA
Sec formed at each time point was
calculated by dividing the intensity of the Cys-[
32P]AMP spot by the total intensity. The experiment was carried out in duplicate.
Figure 6. PLP recognition. Stereo views of (A) Ribbon representation
of the active site of MMPSepSecS in the dimer interface between chains
A and B that are colored pink and blue, respectively. The PLP
molecule is covalently bound to Lys278 of chain A. The Fo Fc omit
map of the PLP molecule, contoured at 3.5 s, is shown. (B) The amino
acid residues that recognize the PLP molecule. The residues of chains
A and B are colored pink and blue, respectively. The Fo Fc omit map
(contoured at 3.5 s) of all of the residues and PLP is shown.
1196 Nucleic Acids Research, 2008, Vol. 36, No. 4The least conserved of these residues is a strictly conserved
proline (Pro169) in the archaeal sequences, while the
residue is conserved as a cysteine in 78% of the eukaryotic
sequences. Interestingly, Pro169 in MMPSepSecS is in the
active site and in close contact with the PLP moiety
(3.77A ˚ at closest approach), which would then mean that
most eukaryotic SepSecSs have a cysteine adjacent to
the PLP. It is unclear whether the eukaryotic sequences
make use of this cysteine in catalysis; nevertheless, this
position is an intriguing candidate for mutagenesis in the
eukaryotic context.
Concerning the archaeal SepSecSs, there are no cysteine
residues that could be involved in the formation of a
catalytically important perselenide intermediate. In con-
trast, SepCysS is proposed to use a persulﬁde mechanism
(18). Thus, SepSecS and SepCysS, two related PLP
enzymes that perform chemically analogous tRNA-
dependent transformations of Sep to Sec or Cys,
respectively, proceed with diﬀerent selenium and sulfur
transfer mechanisms. Based on the observed active site
residues we propose that the arginine residues, that bind
the phosphate groups of PLP and of Sep, also recruit the
selenium donor selenophosphate. In this context, Arg307
in the present structure resides at a similar position to that
of Cys364 in ECCsdB and of Cys247 in AFSepCysS.
Structural phylogenyof Fold TypeI PLP enzymes
SepSecS belongs to the largest and most diverse family of
PLP-dependent enzymes found in nature. The evolution-
ary history of the Fold Type I PLP-dependent enzymes,
also referred to as the a-family, has been studied in
detail with sequence-based phylogenetic methods (43). By
applying the family proﬁle analysis (FPA) technique (44),
the authors were able to use sequence-based phylogenetics
to partially capture the distant evolutionary events
recorded in the sequences of the members of this family,
some of whom share only 5% sequence identity. However,
the low level of sequence similarity may lead to artifacts in
the tree reconstruction process. Since crystal structures for
most members of this protein family exist, we applied
the technique of structural phylogeny (45) to explore the
history of the Fold Type I family. This technique derives
phylogenetic information directly from three-dimensional
structures and thus allows an accurate reconstruction
of the most distantly detectable evolutionary events. Our
structural phylogeny (Figure 3) is largely in agreement
with the previous sequence-based work, but some
signiﬁcant rearrangements in the tree can be seen. For
example, the DC I and DC II subfamilies coalesce into a
single subfamily according to structural similarity, and the
g-lyase and CYS groups are not one but two evolutionary
distinct subfamilies.
There are two kinds of subfamilies in the Fold Type I
group. The ﬁrst type includes several proteins with distinct
but related functions, which may have descended from a
progenitor with a promiscuous enzymatic function.
Examples of these progenitor enzymes include the four
distinct aminotransferases (AT I–AT IV), an amino acid
decarboxylase (DC I/II), a persulﬁde forming cysteine
desulfurase/sulfhydrylase and ﬁnally separate b- and
Figure 8. The active site. Close-up stereo views of the active site regions
in MMPSepSecS, ECCsdB, and AFSepCysS. Chains A and B are
colored pink and blue, respectively. The PLP molecule (shown as a ball
and stick model) is covalently bound to chain A. (A) The recognition
manner of the sulfate ion in the active site of MMPSepSecS. The
sulfate ion is shown as a ball-and-stick model. The Fo Fc omit map of
the sulfate ion, contoured at 4.5 s, is shown. (B) Sec docking model
of MMPSepSecS, based on the structural comparison with ECCsdB.
(C) Sep binding model of MMPSepSecS, based on the locations of the
sulfate ion and Sep. (D) Close-up view of the active site region in
ECCsdB. The PLP molecule is covalently bound to Lys226 of chain A.
The orientation of the PLP molecule is the same as that in (A).
The chain A residues that recognize PLP are shown. The PLP molecule
is covered by the bab structural motif. (E) Close-up view of the
active site region in AFSepCysS. The PLP molecule is covalently
bound to Lys209 of chain A. The orientation of PLP is the same as
that in (A). The chain A residues that recognize PLP and sulfate are
shown.
Nucleic Acids Research, 2008, Vol. 36, No. 4 1197g-amino acid lyases. Subsequent evolution in each of these
subfamilies ultimately produced the speciﬁc enzymatic
functions observed in modern PLP-dependent enzymes.
The second kind of subfamilies are those that include a
set of isofunctional enzymes. The modern enzymes in
these subfamilies trace back to ancestors that had already
evolved their modern enzymatic speciﬁcity in the initial
evolutionary radiation of the Fold Type I family. These
isofunctional subfamilies include serine hydroxymethyl
transferase, alliinase and an archaeal SelA-like protein
(MJ0158), which is of unknown function.
Importantly, the structural phylogeny allows the
accurate placement of SepSecS within its family tree and
reveals how this enzyme came into being. SepSecS is also a
founding member of the Fold Type I family. It shows no
speciﬁc relationship to any of the other subfamilies and
emerges near the root of its family tree. While SepCysS,
CsdB and IscS are part of a multifunctional subfamily
(CYS in Figure 8) and these proteins have chemically
similar substrates to SepSecS, there is no special relation-
ship between SepSecS and the CYS subfamily. This result
indicates that SepSecS is truly an ancient enzyme, and thus
tRNA-dependent selenocysteine biosynthesis is a primor-
dial process.
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